Log In
Print
BCIQ
Print
Print this Print this
 

Cervarix

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHPV types 16 and 18 vaccine formulated with adjuvant AS04
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationHuman papillomavirus (HPV)
Indication DetailsPrevent HPV infection; Protect against HPV infection; Protect against precancerous lesions and cervical cancer caused by HPV types 16 and 18; Treat HPV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1.2M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today